At all levels of society, autism spectrum disorders (ASDs) are exacting a heavy toll. On a purely economic level, the demand for special services and care for an escalating number of autistic children (and, increasingly, adults) is stretching
families,
schools and
health care systems to the breaking point. In 2014, a comprehensive analysis of
ASD costs published in
JAMA Pediatrics placed autism's annual financial impact in the U.S. at $236-$262 billion-roughly seven times more than the $35 billion estimated in
2007.
Some researchers, improbably and disingenuously, still
dispute whether the increase in autism prevalence is "real." However, a
new study in the
Journal of Autism and Developmental Disorders carefully strives to lay any lingering doubts about the ASD epidemic's alarming momentum to rest. In fact, using the best data currently available, the study shows a consistent and strong upward trend and a rate of increase that has accelerated over time and particularly since the late 1980s.
Comment: More information on the health benefits of berberine and PQQ: